O
Octagon Research Solutions Inc.
Pharmaceutical clinical and regulatory information management solutions
About Octagon Research Solutions Inc.
Octagon Research Solutions, Inc. was a company that provided clinical and regulatory information management solutions and software specifically for the pharmaceutical industry. Founded in 1999 by James C. Walker and his twin brother Neal Walker, the company was established to transform clinical research and development through a combination of outsourced services, strategic consulting, and technology. James Walker, who served as Chairman and CEO, started the company with just $5,000 and grew it into a multinational corporation. The firm was headquartered in Wayne, Pennsylvania, with additional operations in the UK and India.
Octagon's core business involved offering software-enabled services for clinical data management and regulatory submissions. These services were designed to help biotechnology and pharmaceutical companies reduce costs, increase efficiency, and improve the quality of their drug approval submissions to global authorities like the U.S. Food and Drug Administration (FDA) and Health Canada. The company developed a reputation for its deep technical regulatory expertise and became the fifth-largest user of the FDA's electronic submission gateway. Its solutions spanned the drug development lifecycle, from initial data collection and clinical programming to the final regulatory submission, utilizing platforms like its ViewPoint Quantum for collaborative document authoring.
Serving over 300 clients, Octagon specialized in helping life sciences companies navigate the complex process of bringing new drugs to market more quickly and cost-effectively. The business model combined software products with a strong service component, including strategic consulting and outsourcing for regulatory affairs. In September 2012, after raising approximately $17.3 million in venture capital from investors like Edison Partners, Octagon was acquired by Accenture for an undisclosed amount. The acquisition was intended to enhance Accenture's life sciences division by integrating Octagon's specialized regulatory capabilities and software with Accenture's global delivery network and business process outsourcing (BPO) services. At the time of the acquisition, Octagon employed around 380 to 450 people.
Source: Dealroom company dataNews
Open roles
Octagon Research Solutions Inc. in the Easttown Township ecosystem
The Octagon Research Solutions Inc. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Edison Partners
Activate Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Octagon Research Solutions Inc. on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Octagon Research Solutions Inc. on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.